OT Genome Fund I, LLC is a private investment fund based in Boston, Massachusetts. According to its most recent Form D, filed Apr 8, 2021, it has sold $3,625,000 of interests to 22 investors since its first sale in Feb 2021. The minimum investment it accepts from an outside investor is $100,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include LLC OT Management; LLC Assure Fund Management II; Richard Thoms.
- Total raised
- $3,625,000Cumulative sales reported on Form D
- Investors
- 22
- First sale
- Feb 3, 2021
- Minimum investment
- $100,000
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- LLC OT Management; LLC Assure Fund Management II; Richard Thoms
- Latest Form D
- Apr 8, 2021
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Apr 8, 2021 | Form D/A (amendment) | $3,625,000 | 22 | SEC.gov ↗ |
| Feb 10, 2021 | Form D | $3,550,000 | 20 | SEC.gov ↗ |
2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Feb 10, 2021. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about OT Genome Fund I, LLC
What is the minimum investment for OT Genome Fund I, LLC?
According to its latest Form D, filed Apr 8, 2021, the minimum investment OT Genome Fund I, LLC accepts from an outside investor is $100,000.
Who can invest in OT Genome Fund I, LLC?
OT Genome Fund I, LLC is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has OT Genome Fund I, LLC raised?
OT Genome Fund I, LLC reports $3,625,000 sold from 22 investors on its Form D filed Apr 8, 2021. This is cumulative sales since the offering began, not current assets or performance.
Where is OT Genome Fund I, LLC based?
OT Genome Fund I, LLC is based in Boston, Massachusetts.
When did OT Genome Fund I, LLC launch?
OT Genome Fund I, LLC reports its first sale in Feb 2021.
Size compared with every private investment fund
Raised more than 35% of the 539 private investment funds based in Massachusetts, and more than 28% of all 10,355 that report sales.
Other funds with the same team
More private investment funds in Boston
- Acadian U.S. Micro/Small-Cap Equity Portable Alpha Fund, LLC$1.7M
- NHIT: Core Plus Fixed Income Trust$4.2B
- Bain Capital Senior Loan Fund, L.P.$3.3B
- Acadian U.S. Managed Volatility Equity Fund, LLC$91.7M
- Acadian Emerging Markets Small-Cap Equity Fund, LLC$2.3B
- Acadian Emerging Markets Managed Volatility Equity Fund, LLC$664M